MoneyWorks4Me

Medico Remedies - Quaterly Results

09 May 2024 Evaluate
The Sales for the quarter ended March 2024 of Rs. 413.23 millions rose by 47.62% from Rs. 279.92 millions.Profit for the quarter ended March 2024 rises by 75.38% to Rs. 30.99  millions from Rs. 17.67 millions.Operating profit for the quarter ended March 2024 rose to 52.30 millions as compared to 32.06 millions of corresponding quarter ended March 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202403 202303 % Var 202403 202303 % Var 202403 202303 % Var
Sales 413.23 279.92 47.62 1449.21 1404.37 3.19 1449.21 1404.37 3.19
Other Income 5.84 0.42 1290.48 21.28 39.47 -46.09 21.28 39.47 -46.09
PBIDT 52.30 32.06 63.13 150.38 135.67 10.84 150.38 135.67 10.84
Interest 2.47 2.06 19.90 8.24 7.47 10.31 8.24 7.47 10.31
PBDT 49.83 30.00 66.10 142.14 128.20 10.87 142.14 128.20 10.87
Depreciation 7.38 7.26 1.65 28.79 27.20 5.85 28.79 27.20 5.85
PBT 42.45 22.74 86.68 113.35 101.00 12.23 113.35 101.00 12.23
TAX 11.46 5.07 126.04 30.44 28.57 6.55 30.44 28.57 6.55
Deferred Tax -0.46 0.70 -165.71 -1.22 3.62 -133.70 -1.22 3.62 -133.70
PAT 30.99 17.67 75.38 82.91 72.43 14.47 82.91 72.43 14.47
Equity 82.98 82.98 0.00 82.98 82.98 0.00 82.98 82.98 0.00
PBIDTM(%) 12.66 11.45 10.50 10.38 9.66 7.41 10.38 9.66 7.41
Peers
Company Name CMP
Sun Pharma. Inds. 1864.00
Dr. Reddys Labs. 1140.80
Cipla 1380.00
Lupin 2075.00
Zydus Lifesciences 1118.00
View more..